Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Bioequivalence Study on Two Paracetamol Tablet Formulations

NCT03562780 is registered in ClinicalTrials.gov with Fortune Pharmacal Co., Ltd. as lead sponsor.

NCT NCT03562780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03562780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Bioequivalence Study on Two Paracetamol Tablet Formulations
Lead sponsor
Fortune Pharmacal Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2018
Completion date
April 8, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy